Company / Current Liabilities per Share
West Pharmaceutical Services Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$9.06
FY2025
5-year range
$6.99 / $9.07
FY2021-FY2025
Trend
+21.0%
vs FY2024
Sector context
#55 of 158
Health Care
What the data says
At $9.06, West Pharmaceutical Services's current liabilities per share ranks #104 of 158 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $3.33 in FY2016 to $9.07 in FY2023.
Based on SEC 10-K filings.
9.06 in FY2025 with a 5-year CAGR of +5.9%.
Remained stable around $9.06 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
-69.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 21.0% year-over-year.
- Ranks #55 out of 158 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.06 | +21.0% |
| FY2024 | $7.49 | -17.4% |
| FY2023 | $9.07 | +29.6% |
| FY2022 | $6.99 | -12.9% |
| FY2021 | $8.03 | +18.2% |
| FY2020 | $6.79 | +47.4% |
| FY2019 | $4.61 | +20.1% |
| FY2018 | $3.84 | +0.4% |
| FY2017 | $3.82 | +14.7% |
| FY2016 | $3.33 | -24.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026